TELA (STOCKS)
TELA Bio, Inc. Common Stock
$0.560300
-0.007100 (-1.25%)
Prev close: $0.567400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Antony Koblish
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.06M
- Employees
- 209
- P/E (TTM)
- -0.67
- P/B (TTM)
- 4.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.17 | $-0.19 | +0.0163 | +8.75% |
|
Sep 2025 (Q3)
|
$-0.19 | $-0.20 | +0.0130 | +6.40% |
|
Jun 2025 (Q2)
|
$-0.22 | $-0.18 | -0.0397 | -22.02% |
|
Mar 2025 (Q1)
|
$-0.25 | $-0.20 | -0.0505 | -25.31% |
Financial Statements
| Revenues | $80.28M |
| Benefits Costs and Expenses | $118.88M |
| Cost Of Revenue | $25.93M |
| Costs And Expenses | $118.88M |
| Gross Profit | $54.34M |
| Nonoperating Income/Loss | -$4.85M |
| Operating Expenses | $88.10M |
| Research and Development | $9.22M |
| Other Operating Expenses | $78.88M |
| Operating Income/Loss | -$33.76M |
| Income/Loss From Continuing Operations After Tax | -$38.83M |
| Income/Loss From Continuing Operations Before Tax | -$38.60M |
| Income Tax Expense/Benefit | $230.00K |
| Income Tax Expense/Benefit, Current | $86.00K |
| Income Tax Expense/Benefit, Deferred | $144.00K |
| Net Income/Loss | -$38.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.83 |
| Diluted Earnings Per Share | -$0.83 |
| Basic Average Shares | 46,947,932 |
| Diluted Average Shares | 46,947,932 |
| Assets | $81.42M |
| Current Assets | $75.58M |
| Accounts Receivable | $10.35M |
| Inventory | $11.02M |
| Other Current Assets | $54.22M |
| Noncurrent Assets | $5.84M |
| Fixed Assets | $2.23M |
| Intangible Assets | $1.36M |
| Other Non-current Assets | $2.25M |
| Liabilities | $75.11M |
| Current Liabilities | $17.98M |
| Accounts Payable | $2.31M |
| Wages | $7.10M |
| Other Current Liabilities | $8.57M |
| Noncurrent Liabilities | $57.13M |
| Equity | $6.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.31M |
| Liabilities And Equity | $81.42M |
| Net Cash Flow From Operating Activities | -$28.22M |
| Net Cash Flow From Operating Activities, Continuing | -$28.22M |
| Net Cash Flow From Investing Activities | $846.00K |
| Net Cash Flow From Investing Activities, Continuing | $846.00K |
| Net Cash Flow From Financing Activities | $25.75M |
| Net Cash Flow From Financing Activities, Continuing | $25.75M |
| Net Cash Flow | -$1.62M |
| Net Cash Flow, Continuing | -$1.62M |
| Comprehensive Income/Loss | -$38.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$38.83M |
| Other Comprehensive Income/Loss | $1.00K |